Forecasting Multidimensional Poverty: South Africa’s Policy Design

By HEOR Staff Writer

April 1, 2024

Introduction:

South Africa is taking a novel approach to tackle poverty. Going beyond income deprivation, the new multidimensional poverty forecasting (MDP) model, provides valuable insights for policy design. The result is a policy instrument that may be employed to formulate anti-poverty measures and evaluate their effectiveness, taking into account variables beyond only the lack of income, such as education, health, and living conditions.

A Groundbreaking Multidimensional Poverty Forecasting

Poverty, in all its forms, is a complex issue. Traditional income-based measures often fall short in capturing its true scope. In response, Applied Development Research Solutions (ADRS) has recently published a report, Multidimensional Poverty: Future Proof with Linked Macro-Micro Modelling. This study presents a pioneering approach to predict and plan for future MDP in South Africa. This new strategy can improve anti-poverty measures and evaluate their impact from 2024 to 2030.

The Dynamic Innovation: DIMMSIM Model

The study employs the DIMMSIM (Dynamic Integrated Macro-Micro Simulation Model) developed by ADRS Global. This model integrates macro (national) and micro (individual/household) data, offering a comprehensive picture of poverty beyond income levels. This lets the model predict future economic trends and their effects on poverty indicators at the national and sub-national levels and by gender, race, and area. It also allows for dynamic simulations of various policy scenarios, offering valuable insights into the potential effectiveness of different anti-poverty strategies.

Robust Predictions for Effective Policy Design

The DIMMSIM model draws its data from the extensive South African General Household Survey. This survey encompasses over 125,000 individuals from nearly 62,000 families. The vastness of this dataset roots the model’s predictions in real-world data, enhancing the reliability of forecasts. The model predicts future poverty trends and assesses potential policy impacts. This tool equips policymakers to craft more targeted and efficient strategies to combat poverty.

South Africa Leading the Global Fight Against Poverty

With this forward-looking tool, South Africa is poised to lead the global fight against poverty. The model’s ability to integrate multidimensional poverty into policy dialogue, planning, healthcare and design has significant implications, not only for South Africa but also for achieving the Sustainable Development Goals.

Conclusion:

This innovative methodology for poverty forecasting signifies a substantial advancement in the global effort to combat poverty. By incorporating multidimensional poverty into policy formulation, South Africa is setting a precedent for more effective anti-poverty strategies. This could have profound implications for health economics, both in South Africa and globally. As poverty is a significant determinant of health outcomes, a more nuanced understanding of its dimensions could facilitate better resource allocation, improved health service delivery, and ultimately, enhanced population health. This could be a game-changer for health economists and policymakers worldwide, providing a more holistic perspective to drive health equity.

Reference url

Recent Posts

Weight Loss: Advances in Hormone-Based Obesity Treatments

By HEOR Staff Writer

November 12, 2025

Advances in Hormone-Based Pharmacotherapies for Obesity Hormone-based obesity treatments are improving the approach to weight management by targeting the body's neurometabolic systems. A recent
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
NICE's Unified Prioritization Roadmap NICE NHS prioritization has led to a new, unified framework and board that will tackle emerging healthcare innovations while managing finite assessment capacity. The approach focuses on high-impact areas, including mental health, early cancer detect...
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adult NF1 Patients

By HEOR Staff Writer

November 7, 2025

European Commission Approves Koselugo for Adult NF1 Patients The European Commission has granted approval for Koselugo (selumetinib), an oral MEK inhibitor developed by Alexion, AstraZeneca Rare Disease, to treat symptomatic, inoperable plexiform neurofibromas in adult patients with neu...